相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Inflammation in Experimental Models of α-Synucleinopathies
Ashley S. Harms et al.
MOVEMENT DISORDERS (2021)
Endothelial S1P1 Signaling Counteracts Infarct Expansion in Ischemic Stroke
Anja Nitzsche et al.
CIRCULATION RESEARCH (2021)
Sphingosine-1-Phosphate Receptors Modulators Decrease Signs of Neuroinflammation and Prevent Parkinson's Disease Symptoms in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model
Elise Pepin et al.
FRONTIERS IN PHARMACOLOGY (2020)
Subclinical Cardiac Microdamage, Motor Severity, and Cognition in Parkinson's Disease
Chi-un Choe et al.
MOVEMENT DISORDERS (2020)
FTY720 Improves Behavior, Increases Brain Derived Neurotrophic Factor Levels and Reduces α-Synuclein Pathology in Parkinsonian GM2+/- Mice
Guadalupe Vidal-Martinez et al.
NEUROSCIENCE (2019)
Blood NfL A biomarker for disease severity and progression in Parkinson disease
Chin-Hsien Lin et al.
NEUROLOGY (2019)
Analyses of sphingosine-1-phosphate in the context of transfusion: how much is in stored blood products and in patient blood?
Annika Poppe et al.
TRANSFUSION (2019)
Neuroprotective effects of fingolimod in mouse models of Parkinson's disease
Peng Zhao et al.
FASEB JOURNAL (2017)
Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington's disease
Alba Di Pardo et al.
SCIENTIFIC REPORTS (2017)
Reference intervals for serum sphingosine-1-phosphate in the population-based Study of Health in Pomerania
Eileen Moritz et al.
CLINICA CHIMICA ACTA (2017)
Fingolimod modulates multiple neuroinflammatory markers in a mouse model of Alzheimer's disease
Nurgul Aytan et al.
SCIENTIFIC REPORTS (2016)
Combination of the Immune Modulator Fingolimod With Alteplase in Acute Ischemic Stroke A Pilot Trial
Zilong Zhu et al.
CIRCULATION (2015)
SPHINGOSINE KINASE 2 AND SPHINGOSINE-1-PHOSPHATE PROMOTES MITOCHONDRIAL FUNCTION IN DOPAMINERGIC NEURONS OF MOUSE MODEL OF PARKINSON'S DISEASE AND IN MPP+-TREATED MN9D CELLS IN VITRO
M. Sivasubramanian et al.
NEUROSCIENCE (2015)
Critical role of sphingosine-1-phosphate receptor-2 in the disruption of cerebrovascular integrity in experimental stroke
Gab Seok Kim et al.
NATURE COMMUNICATIONS (2015)
Targeting blood-brain barrier sphingolipid signaling reduces basal P-glycoprotein activity and improves drug delivery to the brain
Ronald E. Cannon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
分享论文
